Original article: general thoracic
The value of a noninvasive diagnostic approach to mediastinal masses

https://doi.org/10.1016/S0003-4975(02)04726-4Get rights and content

Abstract

Background

Mediastinal tumors show a wide variability, and therefore, a standardized diagnostic and therapeutic workup is instrumental. We subdivided mediastinal tumors into nonlymphatic mediastinal tumors (NLMTs), most of which require surgical resection without need of preoperative histology, and mediastinal lymphadenopathy (MLA), requiring surgical biopsy for exact histologic classification. We investigated the accuracy of noninvasive diagnostic studies distinguishing between the two groups of MLA and NLMT.

Methods

A retrospective analysis was performed on patients who had previously undergone surgery on mediastinal tumors. Their data were statistically analyzed (χ2 test, logistic regression analysis), and the values of medical history, physical examination, laboratory tests, and computerized tomography scan discriminating between MLA and NLMT were assessed.

Results

Out of 299 patients included in the study, 242 (80.9%) had MLA and 57 (19.1%) had NLMT. Sensitivity and specificity of noninvasive investigations for differentiation of MLA and NLMT were 98.2% and 86.0%, respectively. Whereas the prevalence of thoracic symptoms such as shortness of breath, cough, or chest pain was similar in both groups (MLA, 165 [69.3%]; NLMT, 41 [69.5%]; p = 0.98), systemic symptoms, including fever, night sweats, or weight loss (MLA, 110 [49.8%]; NLMT, 17 [29.3%]; p < 0.01), and signs of inflammation, such as c-reactive protein, erythrocyte sedimentation rate, and leukocytosis (MLA, 202 [85.6%]; NLMT, 34 [57.6%]; p < 0.001), were significantly more common in MLA.

Conclusions

Noninvasive diagnostic procedures, including medical history, physical examination, laboratory tests, and computerized tomographic scan, are highly sensitive in detecting MLAs that should undergo surgical biopsy. Our data suggest confirming all suspected NLMTs by fine needle aspiration (FNA) biopsy before surgery.

Section snippets

Material and methods

All records from our clinic between January 1986 and July 1999 were reviewed to identify patients with mediastinal tumors. Patients were only eligible if histology had been established and sufficient data about medical history, physical examination, and diagnostic findings were obtainable. Patients with esophageal malignancies and hernias into the mediastinum were excluded. Information about the patients was obtained through surgery clinic charts, in-patient records, pathology records,

Results

Between January 1986 and July 1999, 354 patients with mediastinal masses underwent operations in our clinic. After exclusion of esophageal malignancies, cardiac tumors, and hernias, there were 323 patients remaining in our database. Twenty-four patients had to be excluded because of insufficient histologic or diagnostic data. Thus, there were 299 patients included in the study.

Symptoms and signs

Symptoms and signs in our series are shown in Table 2. There were 243 (81.3%) symptomatic patients in our series. The symptomatic population of either group, MLA and NLMT, was 81.2% and 81.4%, respectively. Common symptoms, evenly distributed between both groups, were thoracic symptoms such as shortness of breath, cough, and chest pain.

Systemic symptoms such as weight loss, night sweats, or fever (p = 0.005) and laboratory signs of inflammation such as C-reactive protein, leukocytosis, and

Diagnostic accuracy of noninvasive diagnostic approach

The noninvasive diagnostic approach included medical history, physical findings, laboratory results, chest radiograph, and CT scan. All patients were initially evaluated with posteroanterior and lateral chest radiograph. CT scan was used in 281 (94.0%) patients.

Tumors of uncertain histology

In 35 (11.7%) patients, the entity of the mediastinal mass could not be defined, as to allocate them to the MLA or NLMT groups. Twenty-six of these tumors were histologically diagnosed as MLA: four malignant lymphomas, three sarcoidosis, two lymph node tuberculosis, one nonspecific infectious lymphadenopathy, and 16 metastases. In nine of the unclear mediastinal masses, the histologic evaluation revealed NLMT: three thymic tumors, three mesenchymal tumors, two neurogenic tumors, and one germ

Mediastinal lymphadenopathy

In the MLA group, 216 (90.0%) patients were correctly identified. Four (1.7%) MLAs (one Hodgkin’s, three nonspecific lymphadenopathy) were mistakenly diagnosed as NLMT.

Nonlymphatic mediastinal tumors

Among the patients with NLMT, 37 (67.3%) were correctly diagnosed by noninvasive investigations. In six cases (10.5%), NLMT was confused with LMT (two thymomas, one thymic tumor, one carcinoid, one teratoma, one cystic lymphangioma). The statistical analysis for the noninvasive diagnostic approach is shown in Table 3.

Comment

Given the wide variability of histology presenting as mediastinal mass, a standardized diagnostic and therapeutic workup is instrumental. In our study, we investigated the accuracy of noninvasive diagnostic studies, including medical history, laboratory tests, chest radiograph, and CT scan, representing the common first-line diagnostic approach to mediastinal masses [3]. We addressed the question of whether this basic diagnostic approach is sufficient in separating lymphatic tumors that require

Acknowledgments

We thank Dr Douglas R. Johnston for critically reading the manuscript.

References (15)

  • E.A Bacha et al.

    Surgery for invasive primary mediastinal tumors

    Ann Thorac Surg

    (1998)
  • S.P Benjamin et al.

    Primary tumors of the mediastinum

    Chest

    (1972)
  • R Temes et al.

    Primary mediastinal malignanciesfindings in 219 patients

    West J Med

    (1999)
  • A.J Cohen et al.

    Primary cysts and tumors of the mediastinum

    Ann Thorac Surg

    (1991)
  • K.Y Yoneda et al.

    Mediastinal tumors

    Curr Opin Pulmon Med

    (2001)
  • L.J Kohman

    Approach to the diagnosis and staging of mediastinal masses

    Chest

    (1993)
  • Henry PH, Longo DL. Enlargement of lymph nodes and spleen. In Fauci AS, Braunwald E, Isselbacher KJ, et al, eds....
There are more references available in the full text version of this article.

Cited by (0)

View full text